News publication
Everything we hold that kalkine.com.au published.
Every article we hold from kalkine.com.au.
ASX-listed ECT is acquiring all of Xenica Materials, which holds an exclusive Rice University licence for Flash Joule Heating MXene synthesis, paying 60 million ECT shares in escrow.
Under proactiveinvestors.com ·leads this story in the feed
ASX-listed ECT signed a binding deal to buy Xenica Materials, holding a Rice University licence, and locked in commitments for a placement of up to A$12 million.
Under proactiveinvestors.com ·leads this story in the feed
ASX-listed biotech Starpharma has launched an underwritten shareholder rights issue at 57 cents, seeking roughly $32 million to push its lead cancer drug through first-in-human trials and grow its pipeline.
Under kalkine.com.au ·leads this story in the feed
Ceretas has joined the Australian bourse after an eight-million-dollar share issue to fund development of its portable ultrasound therapy for Alzheimer's, with two brokers co-managing the raise.
Under sharecafe.com.au ·leads this story in the feed
Australian biotech Starpharma has opened a 57-cent shareholder rights issue seeking about $32 million, with Canaccord Genuity underwriting the raise and an oversubscription facility letting holders apply for extra shares.
Also Biotech Dispatch·tipranks.com·kalkine.com.au·Biotech Dispatch
ASX-listed medical imaging AI firm Enlitic has lined up committed funding of about A$15 million via a CDI placement, pending shareholder approvals, and intends a retail share purchase offer.
Under Dealroom ·leads this story in the feed
Deals recorded from kalkine.com.au's coverage. A round is listed once, however many of their articles mention it.
| Company | Stage | Announced | Amount | Investors |
|---|---|---|---|---|
| Environmental Clean Technologies | Unnamed stage | 18 Aug 2026 | ~$10.6m | |
| Starpharma | Unnamed stage | 4 Aug 2026 | $32m | |
| Enlitic Limited | Unnamed stage | 3 Jul 2026 | ~$15m | |
| Ceretas | Unnamed stage | Jul 2026 | $8m |
Companies named in kalkine.com.au's articles, most-covered first.
| Company | What it does | Articles |
|---|---|---|
| Environmental Clean Technologies | 2 | |
| Starpharma | Melbourne-based biotech company advancing DEP HER2-Lutetium oncology program | 2 |
| Xenica Materials | 2 | |
| Automic Group | Investor administration platform exited by Five V Capital | 1 |
| Caravel Securities | 1 | |
| Ceretas | Delivers personalised therapeutic ultrasound for Alzheimer's disease | 1 |
| Computershare | 1 | |
| Enlitic Limited | Focused on transforming medical imaging through AI. | 1 |
| Rice University | 1 | |
| Taurus Capital | 1 | |
| William Marsh Rice University | 1 |
Investors named in kalkine.com.au's articles, most-covered first.
| Investor | What it does | Articles |
|---|---|---|
| Canaccord Genuity Australia | 2 |